Sign in
4

Changes in Ownership

agilon health, inc. Filed Acc 0001209191-23-019722

Chief Strategy & Dev. Officer sold 60,000 shares at $26.09 ($1,565,196)

  • Chief Strategy & Dev. Officer acquired 60,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Desai Veeral Chief Strategy & Dev. Officer 2023-03-16 Option exercise +60,000 $3.00 $180,000 336,729 D: show line 1 in the form
Desai Veeral Chief Strategy & Dev. Officer 2023-03-16 Sale −60,000 $26.09 $1,565,196 276,729 D: show line 2 in the form
Open-market sales · 60,000 sh · avg $26.09 · $1,565,196

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Desai Veeral Chief Strategy & Dev. Officer 2023-03-16 Option exercise · Options (Rights to Buy) −60,000 1,640,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…